SUMMARY A patient with a preoperative diagnosis of myxoedema had triple vessel coronary artery bypass surgery. The perioperative and postoperative course was essentially uneventful. The most appropriate management of a patient with coronary artery disease who has concomitant myxoedema is first to improve myocardial blood flow by relieving coronary obstruction and then to treat the thyroid deficiency. Routine preoperative investigations were performed: haemoglobin (14-6 g/dl); mean corpuscular volume (120 fl (normal range 84-98)); normal platelet and leucocyte counts. Although creatine kinase was raised (100 U/I (normal range 30-140 U/1)), the concentration of the isoenzyme creatine kinase was within normal limits. The electrocardiogram showed low voltages with widespread T wave flattening and minimal ST depression in chest leads V4 to V6. There were no specific changes suggestive of myocardial infarction.
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Management of patients with concomitant myxoedema and coronary artery disease is difficult.' In 1938 Smyth described the clinical dilemmas associated with providing adequate thyroid hormone replacement therapy in such patients.2 Thyroxine supplementation commonly increases anginal symptoms, and progression to myocardial infarction has been reported.3 This is a particular problem when the myocardial disease is considered suitable for coronary artery revascularisation. Paine et al reported one death in six patients after attempted preoperative hormone replacement.' To date, there has not been a large study of the diagnosis and subsequent management of hypothyroid patients with chest pain. In patients with myxoedema coronary artery disease tends to be more extensive4 than usual and these patients require detailed and careful investigation.
We present a case report which we believe lends support to a specific and useful form of management by adequate investigation followed by coronary artery revascularisation and postoperative thyroid hormone replacement therapy. Routine preoperative investigations were performed: haemoglobin (14-6 g/dl); mean corpuscular volume (120 fl (normal range 84-98)); normal platelet and leucocyte counts. Although creatine kinase was raised (100 U/I (normal range 30-140 U/1)), the concentration of the isoenzyme creatine kinase was within normal limits. The electrocardiogram showed low voltages with widespread T wave flattening and minimal ST depression in chest leads V4 to V6. There were no specific changes suggestive of myocardial infarction.
We thought that the initial haematological and biochemical findings together with the clinical and electrocardiographic findings suggested a diagnosis of myxoedema. Thyroid function tests were performed. These showed a free thyroxine value of 4pmol/I (normal range 9-26), thyroid stimulating hormone 33 mU/l (normal range 0-5). The diagnosis of myxoedema was confirmed immediately before operation. The operation was performed as planned with reverse saphenous vein grafting into the three main vessels; each graft required endarterectomy.
Although the procedure was carried out under controlled hypothermia the patient's temperature was 37-5°C when he came off bypass. The patient's postoperative course was essentially uneventful; however, he did require dopamine support (5 jg/kg/min in reducing dosage) for twelve hours after operation. His temperature fell to 35-3°C when he returned to the recovery ward. It remained at this level for 24 hours and was not normal until 48 hours after operation. Twenty four hours after operation, he was extubated and was started on L-thyroxine 25 ig/day; the dose was gradually increased over ten days to 100 jg/day.
He was discharged 14 days after operation and remained well and symptom free until four months after operation when anginal symptoms returned. At this stage his haemoglobin was 6-0 g/dl and mean corpuscular volume was 98 fl; serum vitamin B12 Operation in myxoedematous patients is more hazardous because of the increased risks of infection, cardiovascular instability and collapse, respiratory depression, paralytic ileus, and of the development of an inappropriate antidiuretic hormone-like syndrome. In addition body tissue is more friable. These potential problems must be weighed against the real danger of the complications associated with medical management. Once surgery is decided upon, the question of preoperative thyroid hormone replacement therapy must be faced and the conflicting evidence analysed.
Nelson et al reported two patients with myxoedema who underwent coronary artery bypass surgery; one did not have thyroid hormone supplementation before operation.4 His postoperative course was complicated by an inappropriate antidiuretic hormone-like syndrome, paralytic ileus, and infection. The second patient was given a small daily dose of 10.ug thyroxine before operation and did well after operation on a dose of 200 ig of Lthyroxine. The experience of Paine et al, however, suggests that thyroid replacement is not necessary before operation (only one of his series of six patients had a complicated course) and that thyroxine should be introduced gradually after operation with regular assessment of electrocardiograms and serum concentrations of thyroid stimulating hormone. Myerowitz et al found no noticeable improvement in haemodynamic function (cardiac index, left ventricular index, oxygen consumption) in 10 patients treated with small doses of thyroxine before operation.3 They therefore concluded that preoperative treatment offers no clinical or haemodynamic benefit.
The result in our patient supports the view that coronary artery surgery is not contraindicated in cases of untreated myxoedema and that revascularisation can be performed safely in such cases before thyroid replacement therapy, and indeed is the regimen of choice. Mild angina has persisted in our patient although it has become more stable. Because he remains euthyroid we believe that extensive distal disease is the main reason for the persistence of angina.
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